1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 1,267 results.

MDS - 786

Rising Burden of Anemia in Myelodysplastic Syndromes: A 25-Year U.S. Mortality and Disparities Study

Muhammad Ibrahim

Poster Presenter: Muhammad Ibrahim

Thumbnail for Risk-Stratified Survival and Treatment Patterns in MDS: A Nationwide Analysis from the Spanish Group of Myelodysplastic Syndromes (GESMD)

MDS - 790

Risk-Stratified Survival and Treatment Patterns in MDS: A Nationwide Analysis from the Spanish Group of Myelodysplastic Syndromes (GESMD)

Ra?l Azibeiro Melchor

Poster Presenter: Ra?l Azibeiro Melchor

Thumbnail for Sustained Long-Term Control of Terminal Complement Activity With Ravulizumab or Danicopan Add-On to Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria

MDS - 794

Sustained Long-Term Control of Terminal Complement Activity With Ravulizumab or Danicopan Add-On to Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria

Pennie Moore

Poster Presenter: Pennie Moore

Thumbnail for Palliative Care Integration in Transfusion-Dependent Myelodysplastic Syndromes: A Real-World Propensity-Matched TriNetX Cohort Study

MDS - 800

Palliative Care Integration in Transfusion-Dependent Myelodysplastic Syndromes: A Real-World Propensity-Matched TriNetX Cohort Study

Fathima Shehnaz Ayoobkhan

Poster Presenter: Fathima Shehnaz Ayoobkhan

$Thumbnail for Ofirnoflast (HT-6184), a First-in-Class Allosteric NEK7 Inhibitor, Achieves Durable Transfusion Independence (TI) and Hematological Improvement-Erythroid (HI-E) in ESA-Refractory Lower-Risk Myelodysplastic Syndrome (LR-MDS): Phase 2 Final Results$